Trials / Completed
CompletedNCT00607776
Artificial Tears Study in Mild to Moderate Dry Eye Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Abbott Medical Optics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The mean change in the subjective comfort score from baseline of the test group is at least 2.0 units less than that of the control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | (9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 | Drops |
| DRUG | Systane | Drops |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-04-01
- First posted
- 2008-02-06
- Last updated
- 2025-02-03
Source: ClinicalTrials.gov record NCT00607776. Inclusion in this directory is not an endorsement.